▶ 調査レポート

世界の人工臓器&組織市場2022-2028:人工腎臓、人工心臓&補助人工心臓、人工内耳、人工肺、人工肝臓、人工膵臓、義手&義足、その他

• 英文タイトル:Artificial Organ and Tissues Market, Global Outlook and Forecast 2022-2028

Market Monitor Globalが調査・発行した産業分析レポートです。世界の人工臓器&組織市場2022-2028:人工腎臓、人工心臓&補助人工心臓、人工内耳、人工肺、人工肝臓、人工膵臓、義手&義足、その他 / Artificial Organ and Tissues Market, Global Outlook and Forecast 2022-2028 / MR2211MG11460資料のイメージです。• レポートコード:MR2211MG11460
• 出版社/出版日:Market Monitor Global / 2022年11月
• レポート形態:英文、PDF、111ページ
• 納品方法:Eメール(納期:2-3日)
• 産業分類:医療機器
• 販売価格(消費税別)
  Single User¥481,000 (USD3,250)▷ お問い合わせ
  Enterprise User¥625,300 (USD4,225)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査資料は次の情報を含め、人工臓器&組織のグローバル市場規模と予測を記載しています。・人工臓器&組織のグローバル市場:売上、2017年-2022年、2023年-2028年
・人工臓器&組織のグローバル市場:販売量、2017年-2022年、2023年-2028年
・世界のトップ5企業、2021年

人工臓器&組織のグローバル市場規模は2021年に000Mドルと評価され、予測期間中に000%のCAGRで2028年までに000Mドルに達すると予測されています。米国市場は2021年に000Mドルと推定されており、中国は2028年までに000Mドルに達すると予測されています。「人工腎臓」セグメントは今後6年間、000%のCAGRで2028年までに000Mドルに成長すると予測されています。

人工臓器&組織のグローバル主要企業は、Fresenius Medical Care、 Cochlear、 Abiomed、 ABBOTT、 Baxter、 B.Braun、 Asahi Kasei Corporation、 Nipro、 MED-EL、 Toray Medical、 Sonova、 Medtronic、 Getinge (Maquet)、 William Demant、 LivaNova (Sorin)、 Terumo、 Hangzhou Nurotron、 Syncardia、 CorWave、 Listent Medical、 Evaheart、 Open Bionics、 OYMotion Technologies、 Mなどです。2021年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル(MMG)社は、人工臓器&組織のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の人工臓器&組織市場:タイプ別、2017年-2022年、2023年-2028年
世界の人工臓器&組織市場:タイプ別市場シェア、2021年
・人工腎臓、人工心臓&補助人工心臓、人工内耳、人工肺、人工肝臓、人工膵臓、義手&義足、その他

世界の人工臓器&組織市場:用途別、2017年-2022年、2023年-2028年
世界の人工臓器&組織市場:用途別市場シェア、2021年
・医療用、臨床研究用

世界の人工臓器&組織市場:地域・国別、2017年-2022年、2023年-2028年
世界の人工臓器&組織市場:地域別市場シェア、2021年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における人工臓器&組織のグローバル売上、2017年-2022年
・主要企業における人工臓器&組織のグローバル売上シェア、2021年
・主要企業における人工臓器&組織のグローバル販売量、2017年-2022年
・主要企業における人工臓器&組織のグローバル販売量シェア、2021年

さらに、当レポートは主要企業のプロファイルを提示します。
Fresenius Medical Care、 Cochlear、 Abiomed、 ABBOTT、 Baxter、 B.Braun、 Asahi Kasei Corporation、 Nipro、 MED-EL、 Toray Medical、 Sonova、 Medtronic、 Getinge (Maquet)、 William Demant、 LivaNova (Sorin)、 Terumo、 Hangzhou Nurotron、 Syncardia、 CorWave、 Listent Medical、 Evaheart、 Open Bionics、 OYMotion Technologies、 M

*************************************************************

・調査・分析レポートの概要
人工臓器&組織市場の定義
市場セグメント
世界の人工臓器&組織市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の人工臓器&組織市場規模
世界の人工臓器&組織市場規模:2021年 VS 2028年
世界の人工臓器&組織市場規模と予測 2017年-2028年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの人工臓器&組織の売上
グローバルトップ3およびトップ5企業、2021年売上ベース
グローバル企業の人工臓器&組織製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:人工腎臓、人工心臓&補助人工心臓、人工内耳、人工肺、人工肝臓、人工膵臓、義手&義足、その他
人工臓器&組織のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:医療用、臨床研究用
人工臓器&組織の用途別グローバル売上・予測

・地域別市場分析
地域別人工臓器&組織市場規模 2021年と2028年
地域別人工臓器&組織売上・予測
北米市場
- アメリカの人工臓器&組織市場規模2017年-2028年
- カナダの人工臓器&組織市場規模2017年-2028年
- メキシコの人工臓器&組織市場規模2017年-2028年
ヨーロッパ市場
- ドイツの人工臓器&組織市場規模2017年-2028年
- フランスの人工臓器&組織市場規模2017年-2028年
- イギリスの人工臓器&組織市場規模2017年-2028年
- イタリアの人工臓器&組織市場規模2017年-2028年
- ロシアの人工臓器&組織市場規模2017年-2028年
アジア市場
- 中国の人工臓器&組織市場規模2017年-2028年
- 日本の人工臓器&組織市場規模2017年-2028年
- 韓国の人工臓器&組織市場規模2017年-2028年
- 東南アジアの人工臓器&組織市場規模2017年-2028年
- インドの人工臓器&組織市場規模2017年-2028年
南米市場
- ブラジルの人工臓器&組織市場規模2017年-2028年
- アルゼンチンの人工臓器&組織市場規模2017年-2028年
中東・アフリカ市場
- トルコの人工臓器&組織市場規模2017年-2028年
- イスラエルの人工臓器&組織市場規模2017年-2028年
- サウジアラビアの人工臓器&組織市場規模2017年-2028年
- UAEの人工臓器&組織市場規模2017年-2028年

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Fresenius Medical Care、 Cochlear、 Abiomed、 ABBOTT、 Baxter、 B.Braun、 Asahi Kasei Corporation、 Nipro、 MED-EL、 Toray Medical、 Sonova、 Medtronic、 Getinge (Maquet)、 William Demant、 LivaNova (Sorin)、 Terumo、 Hangzhou Nurotron、 Syncardia、 CorWave、 Listent Medical、 Evaheart、 Open Bionics、 OYMotion Technologies、 M
...

This report contains market size and forecasts of Artificial Organ and Tissues in Global, including the following market information:
Global Artificial Organ and Tissues Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Artificial Organ and Tissues market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Artificial Kidney Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Artificial Organ and Tissues include Fresenius Medical Care, Cochlear, Abiomed, ABBOTT, Baxter, B.Braun, Asahi Kasei Corporation, Nipro and MED-EL, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Artificial Organ and Tissues companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Artificial Organ and Tissues Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Artificial Organ and Tissues Market Segment Percentages, by Type, 2021 (%)
Artificial Kidney
Artificial Heart & Ventricular Assist Device
Cochlear Implant
Artificial Lung
Artificial Liver
Artificial Pancreas
Bionic Hands & Prosthetics
Others
Global Artificial Organ and Tissues Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Artificial Organ and Tissues Market Segment Percentages, by Application, 2021 (%)
Medical Use
Clinical Research
Global Artificial Organ and Tissues Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Artificial Organ and Tissues Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Artificial Organ and Tissues revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Artificial Organ and Tissues revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Fresenius Medical Care
Cochlear
Abiomed
ABBOTT
Baxter
B.Braun
Asahi Kasei Corporation
Nipro
MED-EL
Toray Medical
Sonova
Medtronic
Getinge (Maquet)
William Demant
LivaNova (Sorin)
Terumo
Hangzhou Nurotron
Syncardia
CorWave
Listent Medical
Evaheart
Open Bionics
OYMotion Technologies
Mobius Bionics

レポート目次

1 Introduction to Research & Analysis Reports
1.1 Artificial Organ and Tissues Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Artificial Organ and Tissues Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Artificial Organ and Tissues Overall Market Size
2.1 Global Artificial Organ and Tissues Market Size: 2021 VS 2028
2.2 Global Artificial Organ and Tissues Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Artificial Organ and Tissues Players in Global Market
3.2 Top Global Artificial Organ and Tissues Companies Ranked by Revenue
3.3 Global Artificial Organ and Tissues Revenue by Companies
3.4 Top 3 and Top 5 Artificial Organ and Tissues Companies in Global Market, by Revenue in 2021
3.5 Global Companies Artificial Organ and Tissues Product Type
3.6 Tier 1, Tier 2 and Tier 3 Artificial Organ and Tissues Players in Global Market
3.6.1 List of Global Tier 1 Artificial Organ and Tissues Companies
3.6.2 List of Global Tier 2 and Tier 3 Artificial Organ and Tissues Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Artificial Organ and Tissues Market Size Markets, 2021 & 2028
4.1.2 Artificial Kidney
4.1.3 Artificial Heart & Ventricular Assist Device
4.1.4 Cochlear Implant
4.1.5 Artificial Lung
4.1.6 Artificial Liver
4.1.7 Artificial Pancreas
4.1.8 Bionic Hands & Prosthetics
4.1.9 Others
4.2 By Type – Global Artificial Organ and Tissues Revenue & Forecasts
4.2.1 By Type – Global Artificial Organ and Tissues Revenue, 2017-2022
4.2.2 By Type – Global Artificial Organ and Tissues Revenue, 2023-2028
4.2.3 By Type – Global Artificial Organ and Tissues Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Artificial Organ and Tissues Market Size, 2021 & 2028
5.1.2 Medical Use
5.1.3 Clinical Research
5.2 By Application – Global Artificial Organ and Tissues Revenue & Forecasts
5.2.1 By Application – Global Artificial Organ and Tissues Revenue, 2017-2022
5.2.2 By Application – Global Artificial Organ and Tissues Revenue, 2023-2028
5.2.3 By Application – Global Artificial Organ and Tissues Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Artificial Organ and Tissues Market Size, 2021 & 2028
6.2 By Region – Global Artificial Organ and Tissues Revenue & Forecasts
6.2.1 By Region – Global Artificial Organ and Tissues Revenue, 2017-2022
6.2.2 By Region – Global Artificial Organ and Tissues Revenue, 2023-2028
6.2.3 By Region – Global Artificial Organ and Tissues Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Artificial Organ and Tissues Revenue, 2017-2028
6.3.2 US Artificial Organ and Tissues Market Size, 2017-2028
6.3.3 Canada Artificial Organ and Tissues Market Size, 2017-2028
6.3.4 Mexico Artificial Organ and Tissues Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Artificial Organ and Tissues Revenue, 2017-2028
6.4.2 Germany Artificial Organ and Tissues Market Size, 2017-2028
6.4.3 France Artificial Organ and Tissues Market Size, 2017-2028
6.4.4 U.K. Artificial Organ and Tissues Market Size, 2017-2028
6.4.5 Italy Artificial Organ and Tissues Market Size, 2017-2028
6.4.6 Russia Artificial Organ and Tissues Market Size, 2017-2028
6.4.7 Nordic Countries Artificial Organ and Tissues Market Size, 2017-2028
6.4.8 Benelux Artificial Organ and Tissues Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Artificial Organ and Tissues Revenue, 2017-2028
6.5.2 China Artificial Organ and Tissues Market Size, 2017-2028
6.5.3 Japan Artificial Organ and Tissues Market Size, 2017-2028
6.5.4 South Korea Artificial Organ and Tissues Market Size, 2017-2028
6.5.5 Southeast Asia Artificial Organ and Tissues Market Size, 2017-2028
6.5.6 India Artificial Organ and Tissues Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Artificial Organ and Tissues Revenue, 2017-2028
6.6.2 Brazil Artificial Organ and Tissues Market Size, 2017-2028
6.6.3 Argentina Artificial Organ and Tissues Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Artificial Organ and Tissues Revenue, 2017-2028
6.7.2 Turkey Artificial Organ and Tissues Market Size, 2017-2028
6.7.3 Israel Artificial Organ and Tissues Market Size, 2017-2028
6.7.4 Saudi Arabia Artificial Organ and Tissues Market Size, 2017-2028
6.7.5 UAE Artificial Organ and Tissues Market Size, 2017-2028
7 Players Profiles
7.1 Fresenius Medical Care
7.1.1 Fresenius Medical Care Corporate Summary
7.1.2 Fresenius Medical Care Business Overview
7.1.3 Fresenius Medical Care Artificial Organ and Tissues Major Product Offerings
7.1.4 Fresenius Medical Care Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.1.5 Fresenius Medical Care Key News
7.2 Cochlear
7.2.1 Cochlear Corporate Summary
7.2.2 Cochlear Business Overview
7.2.3 Cochlear Artificial Organ and Tissues Major Product Offerings
7.2.4 Cochlear Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.2.5 Cochlear Key News
7.3 Abiomed
7.3.1 Abiomed Corporate Summary
7.3.2 Abiomed Business Overview
7.3.3 Abiomed Artificial Organ and Tissues Major Product Offerings
7.3.4 Abiomed Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.3.5 Abiomed Key News
7.4 ABBOTT
7.4.1 ABBOTT Corporate Summary
7.4.2 ABBOTT Business Overview
7.4.3 ABBOTT Artificial Organ and Tissues Major Product Offerings
7.4.4 ABBOTT Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.4.5 ABBOTT Key News
7.5 Baxter
7.5.1 Baxter Corporate Summary
7.5.2 Baxter Business Overview
7.5.3 Baxter Artificial Organ and Tissues Major Product Offerings
7.5.4 Baxter Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.5.5 Baxter Key News
7.6 B.Braun
7.6.1 B.Braun Corporate Summary
7.6.2 B.Braun Business Overview
7.6.3 B.Braun Artificial Organ and Tissues Major Product Offerings
7.6.4 B.Braun Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.6.5 B.Braun Key News
7.7 Asahi Kasei Corporation
7.7.1 Asahi Kasei Corporation Corporate Summary
7.7.2 Asahi Kasei Corporation Business Overview
7.7.3 Asahi Kasei Corporation Artificial Organ and Tissues Major Product Offerings
7.7.4 Asahi Kasei Corporation Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.7.5 Asahi Kasei Corporation Key News
7.8 Nipro
7.8.1 Nipro Corporate Summary
7.8.2 Nipro Business Overview
7.8.3 Nipro Artificial Organ and Tissues Major Product Offerings
7.8.4 Nipro Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.8.5 Nipro Key News
7.9 MED-EL
7.9.1 MED-EL Corporate Summary
7.9.2 MED-EL Business Overview
7.9.3 MED-EL Artificial Organ and Tissues Major Product Offerings
7.9.4 MED-EL Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.9.5 MED-EL Key News
7.10 Toray Medical
7.10.1 Toray Medical Corporate Summary
7.10.2 Toray Medical Business Overview
7.10.3 Toray Medical Artificial Organ and Tissues Major Product Offerings
7.10.4 Toray Medical Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.10.5 Toray Medical Key News
7.11 Sonova
7.11.1 Sonova Corporate Summary
7.11.2 Sonova Business Overview
7.11.3 Sonova Artificial Organ and Tissues Major Product Offerings
7.11.4 Sonova Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.11.5 Sonova Key News
7.12 Medtronic
7.12.1 Medtronic Corporate Summary
7.12.2 Medtronic Business Overview
7.12.3 Medtronic Artificial Organ and Tissues Major Product Offerings
7.12.4 Medtronic Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.12.5 Medtronic Key News
7.13 Getinge (Maquet)
7.13.1 Getinge (Maquet) Corporate Summary
7.13.2 Getinge (Maquet) Business Overview
7.13.3 Getinge (Maquet) Artificial Organ and Tissues Major Product Offerings
7.13.4 Getinge (Maquet) Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.13.5 Getinge (Maquet) Key News
7.14 William Demant
7.14.1 William Demant Corporate Summary
7.14.2 William Demant Business Overview
7.14.3 William Demant Artificial Organ and Tissues Major Product Offerings
7.14.4 William Demant Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.14.5 William Demant Key News
7.15 LivaNova (Sorin)
7.15.1 LivaNova (Sorin) Corporate Summary
7.15.2 LivaNova (Sorin) Business Overview
7.15.3 LivaNova (Sorin) Artificial Organ and Tissues Major Product Offerings
7.15.4 LivaNova (Sorin) Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.15.5 LivaNova (Sorin) Key News
7.16 Terumo
7.16.1 Terumo Corporate Summary
7.16.2 Terumo Business Overview
7.16.3 Terumo Artificial Organ and Tissues Major Product Offerings
7.16.4 Terumo Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.16.5 Terumo Key News
7.17 Hangzhou Nurotron
7.17.1 Hangzhou Nurotron Corporate Summary
7.17.2 Hangzhou Nurotron Business Overview
7.17.3 Hangzhou Nurotron Artificial Organ and Tissues Major Product Offerings
7.17.4 Hangzhou Nurotron Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.17.5 Hangzhou Nurotron Key News
7.18 Syncardia
7.18.1 Syncardia Corporate Summary
7.18.2 Syncardia Business Overview
7.18.3 Syncardia Artificial Organ and Tissues Major Product Offerings
7.18.4 Syncardia Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.18.5 Syncardia Key News
7.19 CorWave
7.19.1 CorWave Corporate Summary
7.19.2 CorWave Business Overview
7.19.3 CorWave Artificial Organ and Tissues Major Product Offerings
7.19.4 CorWave Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.19.5 CorWave Key News
7.20 Listent Medical
7.20.1 Listent Medical Corporate Summary
7.20.2 Listent Medical Business Overview
7.20.3 Listent Medical Artificial Organ and Tissues Major Product Offerings
7.20.4 Listent Medical Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.20.5 Listent Medical Key News
7.21 Evaheart
7.21.1 Evaheart Corporate Summary
7.21.2 Evaheart Business Overview
7.21.3 Evaheart Artificial Organ and Tissues Major Product Offerings
7.21.4 Evaheart Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.21.5 Evaheart Key News
7.22 Open Bionics
7.22.1 Open Bionics Corporate Summary
7.22.2 Open Bionics Business Overview
7.22.3 Open Bionics Artificial Organ and Tissues Major Product Offerings
7.22.4 Open Bionics Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.22.5 Open Bionics Key News
7.23 OYMotion Technologies
7.23.1 OYMotion Technologies Corporate Summary
7.23.2 OYMotion Technologies Business Overview
7.23.3 OYMotion Technologies Artificial Organ and Tissues Major Product Offerings
7.23.4 OYMotion Technologies Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.23.5 OYMotion Technologies Key News
7.24 Mobius Bionics
7.24.1 Mobius Bionics Corporate Summary
7.24.2 Mobius Bionics Business Overview
7.24.3 Mobius Bionics Artificial Organ and Tissues Major Product Offerings
7.24.4 Mobius Bionics Artificial Organ and Tissues Revenue in Global Market (2017-2022)
7.24.5 Mobius Bionics Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer